|NIH Human Embryonic Stem Cell Registry|
|Research Using This Line is Eligible for NIH Funding|
Detailed information for selected cell line:
|NIH Registration Number:||0138|
|NIH Approval Number:||NIHhESC-11-0138|
|Available for Distribution:||Yes|
An MTA must be signed between the requesting investigator and Mount Sinai Hospital, Toronto Canada. A research plan is required and all research must have obtained relevant permissions through the requesting investigator's national regulations. In Canada, research must follow the Stem Cell Oversight Committee guidelines and SCOC approval for the use of the cell lines must be obtained.
NIH-funded research with this line may only be conducted at Mount Sinai Hospital and “other Canadian laboratories affiliated with the Canadian Stem Cell Network for further research or potential clinical use."
|Submitting Organization:||Mt Sinai Hosp-Samuel Lunenfeld Research Institute|
|Provider Name:||Andras Nagy|
|Provider Phone:||416 586-4800 x 3246|
(Emails that are offensive or unrelated to stem cells will be deleted.)